Enioutina, Elena Yurievna, MD, PhD

Research Interests

  • Immunopharmacology
  • Medicine, Herbal
  • Myeloid Derived Suppressor Cells (MDSCs)
  • Neonatal Infections/Sepsis
  • Pharmacology
  • Vaccination
  • Chlamydia Infections

Languages

  • English
  • Russian

Academic Information

  • Departments: Pediatrics - Research Assistant Professor
  • Divisions: Microbiology and Immunology, Pediatric Clinical Pharmacology

Academic Office Information

  • 801-587-1916
  • Williams Building
    295 Chipeta Way, Room: 1S100
    Salt Lake City, UT 84108

Academic Bio

Dr. Elena Yu Enioutina holds an M.D. degree in Preventive medicine and Ph.D. in medicine with specialization in pharmacology and toxicology. She has hands-on experience in immunopharmacology, pharmacology/toxicology, animal modeling as well as extensive academic research experience in immunology, vaccines, and immune senescence. Her long-standing interest in the prophylaxis of infectious diseases goes back to medical school years. Immune senescence and modulation of immune responses in aged animals by cholesterol lowering drugs was the topic of her Ph.D. work. Her current research involves the understanding of the relationship between the activity of cord blood myeloid derived suppressor cells and neonatal susceptibility to infections, and discovering therapeutic options aimed to improve immune responsiveness of newborns.

Education History

Type School Degree
Postdoctoral Fellowship University of Utah School of Medicine
Pathology
Postdoctoral Fellow
Doctoral Training All Union Research Institute of Medicinal Plants (VILAR)
Pharmacology/Immunotoxicology
Ph.D.
Internship I.M. Sechenov First Moscow State Medical University
Preventive Medicine
Intern
Professional Medical I.M. Sechenov First Moscow Institute of Medicine
Medicine
M.D.
Undergraduate I.M. Sechenov First Moscow Institute of Medicine
B.A.

Global Impact

Education History

Type School Degree Country
Doctoral Training All Union Research Institute of Medicinal Plants (VILAR)
Pharmacology/Immunotoxicology
Ph.D. Russia
Internship I.M. Sechenov First Moscow State Medical University
Preventive Medicine
Intern Russia
Professional Medical I.M. Sechenov First Moscow Institute of Medicine
Medicine
M.D. Russia
Undergraduate I.M. Sechenov First Moscow Institute of Medicine
B.A. Russia

Selected Provider Publications

Journal Article

  1. Krepkova LV, Bortnikova VV, Sherwin CM, Enioutina EY (). Clinical significance of the preclinical studies of medicinal herbs affecting reproductive health. J Clin Pharmacol.
    Global Impact: Global, Global, Global, Global, Global.

  2. Enioutina EY, Myers EJ, Tvrdik P, Hoidal JR, Rogers SW, Gahring LC (2015). The nicotinic receptor Alpha7 impacts the mouse lung response to LPS through multiple mechanisms. PLoS ONE, 10(3), e0121128.
    Global Impact: Global, Global, Global, Global, Global.

  3. Tataurova TA, Krepkova LV, Bortnikova VV, Kuznersov YuB, Enioutina EY aka Eniutina EIu (1988). Preclinical toxicological study of glyciram. Farmakol Toksikol, 51(6), 87-90.
    Global Impact: Russia, Russia, Russia, Russia, Russia.

Review

  1. Silvia Martinez-Illamola, Ogochukwu Amaeze, Lubov Krepkova, Angela Burnbaum, Ashwin Karanam, Kate Job, Valentina Bortnikova, Catherine Sherwin, and Elena Enioutina (). Herbal medicine in pregnancy: is it safe? [Review]. J Clin Pharmacol.
    Global Impact: Global, Global, Global, Global, Global.

  2. Enioutina EY, Teng L, Fateeva TV, Brown JCS, Job KM, Bortnikova VV, Krepkova LV, Gubarev MI, Sherwin CMT (2017 Nov). Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance. [Review]. Expert Rev Clin Pharmacol, 10(11), 1203-1214.
    Global Impact: Global, Global, Global, Global, Global.

  3. Barnes J, McLachlan AJ, Sherwin CM, Enioutina EY (2016 Jul). Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. [Review]. Expert Rev Clin Pharmacol, 9(7), 905-15.
    Global Impact: Global, Global, Global, Global, Global.

  4. Sammons HM, Gubarev MI, Krepkova LV, Bortnikova VV, Corrick F, Job KM, Sherwin CM, Enioutina EY (2016 Aug). Herbal medicines: challenges in the modern world. Part 2. European Union and Russia. [Review]. Expert Rev Clin Pharmacol, 9(8), 1117-27.
    Global Impact: Global, Global, Global, Global, Global.

  5. Teng L, Zu Q, Li G, Yu T, Job KM, Yang X, Di L, Sherwin CM, Enioutina EY (2016 Sep). Herbal medicines: challenges in the modern world. Part 3. China and Japan. [Review]. Expert Rev Clin Pharmacol, 9(9), 1225-33.
    Global Impact: Global, Global, Global, Global, Global.

  6. Job KM, Kiang TK, Constance JE, Sherwin CM, Enioutina EY (2016 Dec). Herbal medicines: challenges in the modern world. Part 4. Canada and United States. [Review]. Expert Rev Clin Pharmacol, 9(12), 1597-1609.
    Global Impact: Global, Global, Global, Global, Global.

Abstract

  1. Krepkova LV, Bortnikova VV, Sherwin CM, Enioutina EY (). Clinical implementations of the preclinical studies of medicinal herbs affecting thyroid function: Are they safe for pregnant women? [Abstract]. ACCP 2018 meeting (September 2018).
    Global Impact: Global, Global, Global, Global, Global.

  2. Fateeva T, N Krutivova, L Krepkova, K Job, V Bortnikova, CM Sherwin, E Enioutina (). Combating microbial resistance with phytodrugs [Abstract]. Antimicrobials and Resistance: Opportunities and Challenges, Keystone Symposia Conference, Santa Fe, New Mexico, October-November 2017.
    Global Impact: Global, Global, Global, Global, Global.

  3. Elena Y Enioutina, Jacob Wilkes, Jared Olson, Emily A Thorell, Andrew T Pavia, Catherine M Sherwin, Alfred H Balch (). IVIG patterns among pediatric patients with neoplasms admitted to U.S. pediatric hospital [Abstract]. American College of Clinical Pharmacology Annual Meeting, San Diego; September 2017.
    Global Impact: Global, Global, Global, Global, Global.

  4. Enioutina EY, Balch AH, Wilkes J, Olson J, Thorell EM, Pavia AT, Sherwin CM (). IVIG Patterns Among Pediatric Patients Hospitalized to the Major USA Pediatric Hospitalsλ [Abstract]. American Society for Clinical Pharmacology and Therapeutics Annual Meeting, San Diego, March 2016.
    Global Impact: Global, Global, Global, Global, Global.

Service

Date Role Description Country
11/24/2016 Moderator ASCPT webinar Global
09/01/2017 Reviewer AAPS 2017 meeting Global

Selected Publications

Journal Article

  1. Feldkamp ML, Enioutina EY, Botto LD, Krikov S, Byrne JL, Geisler WM (2015 Nov). Chlamydia trachomatis IgG3 seropositivity is associated with gastroschisis. J Perinatol, 35(11), 930-4.
  2. Enioutina EY, Myers EJ, Tvrdik P, Hoidal JR, Rogers SW, Gahring LC (2015). The nicotinic receptor Alpha7 impacts the mouse lung response to LPS through multiple mechanisms. PLoS ONE, 10(3), e0121128.
  3. Gahring LC, Enioutina EY, Myers EJ, Spangrude GJ, Efimova OV, Kelley TW, Tvrdik P, Capecchi MR, Rogers SW (2013). Nicotinic receptor alpha7 expression identifies a novel hematopoietic progenitor lineage. PLoS ONE, 8(3), e57481.
  4. Contreras YM, Yu X, Hale MA, Callaway CW, Bareyan D, McKnight RA, Joss-Moore LA, Enioutina EY, Lane RH (2011 Aug). Intrauterine growth restriction alters T-lymphocyte cell number and dual specificity phosphatase 1 levels in the thymus of newborn and juvenile rats. Pediatr Res, 70(2), 123-9.
  5. Ahlem CN, Auci DL, Nicoletti F, Pieters R, Kennedy MR, Page TM, Reading CL, Enioutina EY, Frincke JM (2011 Sep). Pharmacology and immune modulating properties of 5-androstene-3beta,7beta,17beta-triol, a DHEA metabolite in the human metabolome. J Steroid Biochem Mol Biol, 126(3-5), 87-94.
  6. Wendorf JR, Ghartey-Tagoe EB, Williams SC, Enioutina E, Singh P, Cleary GW (2011 Jan). Transdermal delivery of macromolecules using solid-state biodegradable microstructures. Pharm Res, 28(1), 22-30.
  7. Enioutina EY, Bareyan D, Daynes RA (2011 Jan 15). A role for immature myeloid cells in immune senescence. J Immunol, 186(2), 697-707.
  8. Enioutina EY, Bareyan D, Daynes RA (2009 Apr 01). TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol, 182(7), 4296-305.
  9. Enioutina EY, Bareyan D, Daynes RA (2008 Jan 30). TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine, 26(5), 601-13.
  10. Heithoff DM, Shimp WR, Lau PW, Badie G, Enioutina EY, Daynes RA, Byrne BA, House JK, Mahan MJ (2008 Mar). Human Salmonella clinical isolates distinct from those of animal origin. Appl Environ Microbiol, 74(6), 1757-66.
  11. Heithoff DM, Enioutina EY, Bareyan D, Daynes RA, Mahan MJ (2008 Nov). Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity. Infect Immun, 76(11), 5191-9.
  12. Heithoff DM, Badie G, Julio SM, Enioutina EY, Daynes RA, Sinsheimer RL, Mahan MJ (2007 Jul). In vivo-selected mutations in methyl-directed mismatch repair suppress the virulence attenuation of Salmonella dam mutant strains following intraperitoneal, but not oral, infection of naive mice. J Bacteriol, 189(13), 4708-17.
  13. Enioutina EY, Bareyan D, Daynes RA (2007 Jan 26). Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine, 25(7), 1236-49.
  14. Daynes RA, Enioutina EY, Jones DC (2003). Role of redox imbalance in the molecular mechanisms responsible for immunosenescence. Antioxid Redox Signal, 5(5), 537-48.
  15. Heithoff DM, Enioutina EY, Daynes RA, Sinsheimer RL, Low DA, Mahan MJ (2001 Nov). Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect Immun, 69(11), 6725-30.
  16. Manning BM, Enioutina EY, Visic DM, Knudson AD, Daynes RA (2001 Dec). CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice. Exp Gerontol, 37(1), 107-26.
  17. Hart PR, Kopeckova P, Omelyanenko V, Enioutina E, Kopecek J (2000). HPMA copolymer-modified avidin: immune response. J Biomater Sci Polym Ed, 11(1), 1-12.
  18. Enioutina EY, Visic VD, Daynes RA (2000 May 08). Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine, 18(22), 2381-93.
  19. Enioutina EY, Visic D, Daynes RA (2000 Jun 01). The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine, 18(24), 2753-67.
  20. Enioutina EY, Visic D, McGee ZA, Daynes RA (1999 Aug 06). The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant. Vaccine, 17(23-24), 3050-64.
  21. Gubarev MI, Enioutina EY, Taylor JL, Visic DM, Daynes RA (1998). Plant-derived glycoalkaloids protect mice against lethal infection with Salmonella typhimurium. Phytother Res, 12, 1-10.
  22. Chen XP, Enioutina EY, Daynes RA (1997 Apr 01). The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase. J Immunol, 158(7), 3070-80.
  23. Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo B A (1996 Apr). Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun, 64(4), 1100-9.
  24. Tataurova TA, Krepkova LV, Bortnikova VV, Kuznersov YuB, Enioutina EY aka Eniutina EIu (1988). Preclinical toxicological study of glyciram. Farmakol Toksikol, 51(6), 87-90.
  25. Jadon S Wagstaff, Rachael M Eason, Michael Newman, Catherine M Sherwin, Elena Y Enioutina (). Neonatal late-onset sepsis: a retrospective analysis of the University of Utah Hospital cases. J Pediatr Pharmacol Ther.
  26. Krepkova LV, Bortnikova VV, Sherwin CM, Enioutina EY (). Clinical significance of the preclinical studies of medicinal herbs affecting reproductive health. J Clin Pharmacol.
  27. Alfred Balch, Jacob Wilkes, Emily Thorell, Andrew Pavia, Catherine Sherwin, Elena Enioutina (). Changing IVIG use in Pediatric Patients: A retrospective review of practices in a network of major US Pediatric Hospitals. Int J Immunopharmacol.

Review

  1. Enioutina EY, Teng L, Fateeva TV, Brown JCS, Job KM, Bortnikova VV, Krepkova LV, Gubarev MI, Sherwin CMT (2017 Nov). Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance. [Review]. Expert Rev Clin Pharmacol, 10(11), 1203-1214.
  2. Enioutina EY, Salis ER, Job KM, Gubarev MI, Krepkova LV, Sherwin CM (2017 Mar). Herbal Medicines: challenges in the modern world. Part 5. status and current directions of complementary and alternative herbal medicine worldwide. [Review]. Expert Rev Clin Pharmacol, 10(3), 327-338.
  3. Yu T, Enioutina EY, Brunner HI, Vinks AA, Sherwin CM (2017 Feb). Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus. [Review]. Clin Pharmacokinet, 56(2), 107-125.
  4. Barnes J, McLachlan AJ, Sherwin CM, Enioutina EY (2016 Jul). Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand. [Review]. Expert Rev Clin Pharmacol, 9(7), 905-15.
  5. Sammons HM, Gubarev MI, Krepkova LV, Bortnikova VV, Corrick F, Job KM, Sherwin CM, Enioutina EY (2016 Aug). Herbal medicines: challenges in the modern world. Part 2. European Union and Russia. [Review]. Expert Rev Clin Pharmacol, 9(8), 1117-27.
  6. Teng L, Zu Q, Li G, Yu T, Job KM, Yang X, Di L, Sherwin CM, Enioutina EY (2016 Sep). Herbal medicines: challenges in the modern world. Part 3. China and Japan. [Review]. Expert Rev Clin Pharmacol, 9(9), 1225-33.
  7. Job KM, Olson J, Stockmann C, Constance JE, Enioutina EY, Rower JE, Linakis MW, Balch AH, Yu T, Liu X, Thorell EA, Sherwin CM (2016 Aug). Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. [Review]. Expert Rev Anti Infect Ther, 14(8), 731-46.
  8. Job KM, Kiang TK, Constance JE, Sherwin CM, Enioutina EY (2016 Dec). Herbal medicines: challenges in the modern world. Part 4. Canada and United States. [Review]. Expert Rev Clin Pharmacol, 9(12), 1597-1609.
  9. Enioutina EY, Constance JE, Stockmann C, Linakis MW, Yu T, Rower JE, Balch AH, Sherwin CM (2015). Pharmacokinetic considerations in the use of antivirals in neonates. [Review]. Expet Opin Drug Metabol Toxicol, 11(12), 1861-78.
  10. Daynes RA, Araneo BA, Hennebold J, Enioutina E, Mu HH (1995 Jul). Steroids as regulators of the mammalian immune response. [Review]. J Invest Dermatol, 105(1 Suppl), 14S-19S.
  11. Job KM, Roberts JK, Enioutina EY, Illamola SM, Kumar S, Rashid J, Sherwin CM, Sherbotie J (). Treatment Optimization of Immunosuppressive Agents in Pediatric Renal Transplant Recipients. [Review]. Pharmacol Res.
  12. Silvia Martinez-Illamola, Ogochukwu Amaeze, Lubov Krepkova, Angela Burnbaum, Ashwin Karanam, Kate Job, Valentina Bortnikova, Catherine Sherwin, and Elena Enioutina (). Herbal medicine in pregnancy: is it safe? [Review]. J Clin Pharmacol.

Book Chapter

  1. Joseph E Rower and Elena Y Enioutina (). HIV/AIDS Disease Model. In Ene I. Ette. (Ed.), Pharmacometrics: The Science of Quantitative Pharmacology. Wiley.

Conference Proceedings

  1. Enioutina E, Daynes RA (2004). Vaccine formulations containing vitamin D3 promote the induction of both mucosal and systemic immunity following either intranasal or subcutaneous administration. Experimental Biology 2004, Washington, DC.
  2. McGee ZA, Daynes RA, Enioutina EY, Kort L (1999). Induction of general mucosal immunity to agents of STD's by hormonally immunomodulated peripheral vaccination (HIPV). 13th Meeting of the International Society for Sexually Transmitted Diseases, Denver, CO.
  3. Enioutina E (1987). Immunosuppressive effects of hypolipidemic drugs derived from Diascorea Nipponica. Ann the 8th Young Scientist's Conference of All-Union Institute of Medicinal Plants, 5-7.

Editorial

  1. Biltaji E, Kumar SS, Enioutina EY, Sherwin CMT (2017 Nov). Can ad hoc analyses of clinical trials help personalize treatment decisions? Br J Clin Pharmacol, 83(11), 2337-2338.

Abstract

  1. Fateeva T, N Krutivova, L Krepkova, K Job, V Bortnikova, CM Sherwin, E Enioutina (). Combating microbial resistance with phytodrugs [Abstract]. Antimicrobials and Resistance: Opportunities and Challenges, Keystone Symposia Conference, Santa Fe, New Mexico, October-November 2017.
  2. Elena Y Enioutina, Jacob Wilkes, Jared Olson, Emily A Thorell, Andrew T Pavia, Catherine M Sherwin, Alfred H Balch (). IVIG patterns among pediatric patients with neoplasms admitted to U.S. pediatric hospital [Abstract]. American College of Clinical Pharmacology Annual Meeting, San Diego; September 2017.
  3. Enioutina EY, Balch AH, Wilkes J, Olson J, Thorell EM, Pavia AT, Sherwin CM (). IVIG Patterns Among Pediatric Patients Hospitalized to the Major USA Pediatric Hospitalsλ [Abstract]. American Society for Clinical Pharmacology and Therapeutics Annual Meeting, San Diego, March 2016.
  4. Constance JE, Balch A, Enioutina EY, Stockmann C, Linakis M, Sherwin CM, Spigarelli M (). Polypharmacy among hospitalized pediatric cancer patients [Abstract]. ASCPT Annual Meeting, New Orleans, March, 2015.
  5. Enioutina EY, Constance JE, Balch AH, Sherwin CM, Spigarelli MG (). Vaccination patterns among pediatric cancer patients treated with IV antibiotics [Abstract]. ASCPT Annual Meeting, New Orleans; March, 2015.
  6. Feldkamp ML, Enioutina EY, Byrne JLB, Bareyan D, Krikov S, Botto LD (). A pilot study of gastroschisis and biomarkers for chlamydia infection and inflammation [Abstract]. 39th Annual Meeting of the International Clearinghouse for Birth Defects Surveillance and Research, Ottawa, Canada.
  7. Feldkamp ML, Enioutina EY, Byrne JLB, Bareyan D, Krikov S, Botto LD (). A pilot study of gastroschisis and biomarkers for chlamydia infection and inflammation [Abstract]. 52nd Annual Meeting of the Teratology Society, Baltimore, MD.
  8. Einoutina EY, Bareyan D, Daynes RA (). Suppressive and myeloid cells as mediators of immune senescence [Abstract]. The Macrophage: Intersection of Pathogenic and Protective Inflammation. Keystone Symposium.
  9. Enioutina EY, Bareyan D, Daynes RA (2009). TLR Induced Local Metabolism of Vitamin D3 Plays an Important Role in Diversification of Adaptive Humoral Immune Responses [Abstract]. Dendritic cells, Keystone Symposium, March-April 2009, Abstract #202.
  10. Enioutina EY, Bareyan D, Daynes RA (2005). Calcitriol expands the lymphoid organ distribution and number of antigen presenting dendritic cells emigrating fro tissue sites of vaccination [Abstract]. Leukocyte Trafficking: Cellular and Molecular mechanisms, Keystone Symposium, March 2005,, Abstract #127.
  11. Enioutina EY, Bareyan D, Daynes RA (2007). The activation of skin dendritic cells with TLR4/3 ligands allows trafficking to the Peyer’s patches and induces mucosal immunity to co-administered antigens. I [Abstract]. Intracellular and Intercellular Signaling in Dendritic Cell Function, Keystone Symposium, February-March 2007, Abstract# 146.
  12. Enioutina EY, Bareyan D, Daynes RA (2006). 1,25-dihydroxyvitamin D3 affects the trafficking of dendritic cells in vivo subsequent to antigen uptake in the skin [Abstract]. Mucosal and regional immunology, Immunology 2006.
  13. Enioutina EY, Bareyan D, Daynes RA (2005). Calcitriol expands the lymphoid organ distribution and number of antigen presenting dendritic cells emigrating fro tissue sites of vaccination [Abstract]. Leukocyte Trafficking: Cellular and Molecular mechanisms, Keystone Symposium, March 2005, Abstract #127.
  14. Daynes RA, Enioutina EY (2005). Vaccine adjuvants that promote the migration of antigen presenting dendritic cells from the skin to Peyer's patches are capable of inducing both systemic and mucosal immune response [Abstract]. Leukocyte Trafficking: Cellular and Molecular Mechanisms, Keystone Symposium, 121.
  15. Enioutina EY, Bareyan D, Narra K, Daynes RA (2004). A role for nitric oxide in the age-associated decline in immune competence. In: Experimental Biology 2004, Washongton, DC [Abstract]. FASEB Journal.
  16. Enioutina EY, Bareyan D, Daynes RA (2004). Vaccine formulations containing vitamin D3 promote the induction of both mucosal and systemic immunity following either intranasal or subcutaneous administration [Abstract]. FASEB Journal.
  17. Enioutina EY, Bareyan D, Lui Q, Manning BM, Visic DM, Daynes RA (2002). Dendritic cell function is altered in aged mice. In: Experimental Biology 2002, New Orleans [Abstract]. FASEB Journal.
  18. Enioutina EY, Rigg RJ, Daynes RA (2001). Immunosteroid treatment of aged mice at vaccination increases antibody responses and elicits a Th1/Th2 profile resembling that of young animals [Abstract]. The 4th annual conference on vaccine research, Arlington, VA 2001, p.74.
  19. Enioutina EY, Daynes RA (2000). The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin [Abstract]. Immunology 2000, Seattle, WA, FASEB Journal, 14(6).
  20. Manning BM, Enioutina EY, Daynes RA (2000). CpG DNA functions as an effective adjuvant for induction of immune responses in aged mice. In: Immunology 2000, Seattle, WA [Abstract]. FASEB Journal, 14(6), A1130.
  21. McGee ZA, Daynes RA, Enioutina EY, Kort L (1999). Induction of general mucosal immunity to agents of STD's by hormonally immunomodulated peripheral vaccination (HIPV) [Abstract]. 13th meeting of the internation society for sexually transmitted diseases, Denver, CO, 38.
  22. McGee ZA, Daynes RA, Enioutina EY, Kort L (1997). Induction of general mucosal immunity against agents of STD's by hormonally immunomodulated peripheral vaccination [Abstract]. HIV-1 infection, mucosal immunity pathogenesis, 115.
  23. Enioutina EY, Butler SS and Daynes RA (1995). Induction of common mucosal immunity to Hepatitis B surface antigen by a modified immunization strategy. In : 9th International Congress of Immunology, San Francisco, CA [Abstract]. Abstracts Book, 3462.
  24. Daynes RA, Araneo BA, Enioutina EY, Dowell T (1994). Cytokine modulation in vivo with vitamin D3 : promotion of common mucosal immunity following a subcutaneous vaccination. In: Experimental Biology 94, Anaheim, CA [Abstract]. FASEB Journal, 8(5), 1632.
  25. Alfred Balch, Jacob Wilkes, Catherine M Sherwin, Elena Enioutina (). Changing Trends in IVIG use for neurological indications in Pediatric Patients: A Retrospective Review of Practices in a Network of Major USA Pediatric Hospitals [Abstract]. ACCP 2018 meeting, Setember 2018.
  26. Jadon S Wagstaff, Rachael M Eason, Michael Newman, Catherine M Sherwin, Elena Y Enioutina (). Characterization and treatments of neonatal late-onset sepsis: a retrospective analysis of the University of Utah Hospital cases [Abstract]. ACCP 2018 meeting (September 2018).
  27. Krepkova LV, Bortnikova VV, Sherwin CM, Enioutina EY (). Clinical implementations of the preclinical studies of medicinal herbs affecting thyroid function: Are they safe for pregnant women? [Abstract]. ACCP 2018 meeting (September 2018).

Other

  1. Enioutina EY (1990). Immunostimulatory effect of Eleuterococcus. Creation and phytochemistry of new medicines (pp. 23-24).
  2. Enioutina E, Simonova IYu (1990). Antimicrobial, antiviral and immunomodulatory effects of extracts derived from medicinal plants. Phytoncides and medicinal plant drugs (pp. 11-12).
  3. Enioutina EY, Beloshapko AA, Shkarenkov AA (1990). Toxicology and side effects of new sedative drugs from medicinal plants. Problems of Drug Toxicology (pp. 56-58).
  4. Gubarev MI, Enioutina EY, Gusev VV (1990). Bioactive plant derivates as potential immunomodulators. Bioactive plant derivates (pp. 97-101).
  5. Enioutina EY, Beloshapko AA, Shkarenkov AA (1989). Animal models in immunotoxicology and allergy. Theoretical and practical questions in biotechnology of experimental animals (pp. 8-9).
  6. Enioutina EY, Rudneva NA (1987). Modulations of immune response and proliferative activity of lymphocytes by hypolipidemic drugs derived from medicinal plants. Immunomodulators and their significance in infectious and non-infectious pathology (pp. 17-20).
  7. Beloshapko AA, Shkarenkov AA, Enioutina EY (1986). Toxicological assays of medicinal plant extracts and possible side effects. Ann of 1st All-Union Institute of Medicinal Plants (p. 27).
  8. Enioutina EY, Bortnikova VV (1985). Immunomodulatory effects of antimicrobial preparations from medicinal plants. Development of medicinal plant drugs (pp. 41-42).
  9. Enioutina EY (1983). Food handling and microbial contamination of school lunches and their influence at the level of enteric diseases of high school students. Ann of 1st Moscow Medical School (pp. 579-583).
  10. Enioutina EY (1983). Influence of microenvironmental conditions on mental and physical development of the Bolshoy Theater Ballet School students. Ann of 1st Moscow Medical School (pp. 157-162).
  11. Enioutina EY (1982). Influence of early smoking and high stress on arterial hypertension in teenagers. Ann of 1st Moscow Medical School (pp. 24-31).
  12. Enioutina EY (1980). Identification and characterization of clinical isolates from gynecological wards of the Medical School Hospital. Ann of 1st Moscow Medical School (pp. 273-279).